Registered Attendees for 10.31.13 First Last Title Company Beth

Total Page：16

File Type：pdf, Size：1020Kb

Registered Attendees for 10.31.13 First Last Title Company Beth Albright SVP, Human Resources Day & Zimmermann Jonathan Berger VP Human Relations Bimbo Bakeries USA Emily Bland Vice President Comcast Joseph Cassidy Vice President, Human Resources Holy Redeemer Health System Douglas Clayton SVP, Learning & Development SES Martin Evans Chief Human Resources Officer BDP International Troy Fee VP-Human Resources AmeriGas Jim Flanagan SVP, CHRO Pep Boys John Forde Consultant Trion Doug German VP Human Resources Endo Health Solutions Susan Gunn Vice President, Human Resources Gardner Denver, Inc. David Howe Exec Dir HR US Market & Global Med Aff Merck & Co., Inc. Donald Hurford Vice President Human Resources Parkway Corporation Paul Jeffers Senior Vice President & CHRO The Penn Mutual Life Insurance Company Andrea Kaelin System Director, Comp & Org. Effectiveness Main Line Health Deb Kauffman VP HR Astrazeneca Rochelle Krombolz Vice-President, HR Americas VWR International Alice Lindenauer Managing Director Hamilton Lane Valerie Mattern VP HR ERT Ania Mikson SVP, Human Resources Delaware Investments Joe O'Brien Managing Director Client Solutions O.C. Tanner Company Assistant Vice President, Talent Management and Cristen Odian Radian Communications Dimitri Pappas Chief Administrative Officer Clement Pappas & Co. Dr. Michael Pepe Senior Partner Meaningful Growth Associates, Inc. Pat Pettinati Chief Human Resources Officer SAP America Linda Pickles Chief Operating Officer Berkadia David Pinette Senior Vice President Challenger, Gray & Christmas, Inc. George Podhor Managing Director O.C. Tanner Company Mary Robinson Director of Human Resources Duane Morris LLP Scott Rosen President The Rosen Group Gilles Rouleau President SAG Consulting Vice President, Organization Development and Chief Judy Schueler Penn Medicine Human Resources Officer Tony Smith Vice President, Human Resources Prudential Felicia Smith CHRO John Templeton Foundation Jeff Sprechini Strategic Account Manager Ultimate Software Theresa Tavernier SVP, Director of Human Resources Capmark Financial Group Inc. Robert Taylor Vice President, HR Jefferson University Pamela Teufel SVP and Chief Human Resources Officer Thomas Jefferson University and Hospitals, Inc. Stacyann Vahey Vice President for Human Resources Thomas Jefferson University and Hospitals, Inc. Valerie Wandler SVP, HR Services ARAMARK Jeanne Marie Welsko SVP of HR (formerly) Drew Wiess Director, HR Programs Airgas. Inc. David Wragg Vice President, Human Resources Unisys.

Copy Link

Recommended publications

Status NOT EQUAL to D
CITY OF SOMERVILLE FY 2021 Page: 1/29 ONE LINE OWNER LISTING Ordered By LOCATION Filter: Status NOT EQUAL TO d Location Account # Owner DBA Tax Code Total 81 ALBION ST 112090 TERRACE DESIGNS INC AVEY ART DISPLAY 502 3,520 83 ALBION ST 135580 FOUR WHEELS AUTO LLC FOUR WHEELS AUTO LLC 501 5,140 99 ALBION ST 136630 HERNANDEZ ALEX HERNANDEZ CONSULTING & 501 9,130 99 ALBION ST 109770 SILLARI T J INC SILLARI T J INC 502 2,210 99 ALBION ST 126530 SHAW DESIGN GROUP LLC CANINE SHOP THE 502 190 99 ALBION ST 133560 SILLARI CAROLINE ROCK TRIBE 501 1,060 112 ALBION ST 104820 ALLEN PLUMBING INC ALLEN PLUMBING INC 502 2,340 105 ALEWIFE BROOK PKWY 128680 STOP & SHOP STOP & SHOP 502 420,120 115 ALEWIFE BROOK PKWY 121390 CONTAN DISCOUNT LIQUOR INC CONTAN DISCOUNT LIQUOR 502 2,800 325 ALEWIFE BROOK PKWY 105540 DUCEUOTTE AUTO DUCEUOTTE AUTO 502 4,460 379 ALEWIFE BROOK PKWY 111540 MOBIL MART PLUS INC GULF 502 20,860 379 ALEWIFE BROOK PKWY 121450 ALLEN JAMES DUNKIN DONUTS 501 25,030 30 ALSTON ST 112570 FLAGRAPHIC INC FLAGRAPHIC INC 502 10,790 300 ARTISAN WAY 130290 NIKE NIKE 502 25,210 301 ARTISAN WAY 130280 EXPRESS FASHION OPERATIONS EXPRESS FACTORY OUTLET 502 3,510 330 ARTISAN WAY 129710 AM RETAIL GROUP WILSONS LEATHER 502 4,540 341 ARTISAN WAY 129660 PUMA NA INC PUMA 502 33,120 360 ARTISAN WAY 129720 STERLING INC KAY JEWELERS #2962 502 4,150 361 ARTISAN WAY 136440 WORLD OF JEANS & TOPS INC TILLYS #263 502 7,440 370 ARTISAN WAY 136450 SAMSONITE COMPANY STORES LLC SAMSONITE COMPANY STOR 503 0 390 ARTISAN WAY 129700 CONVERSE FACTORY CONVERSE FACTORY #3789
[Show full text]
South Dakota Board of Pharmacy Wholesale Distributors; Active, in Good Standing As of October 5, 2018 This Document May Be Used As a Primary Source Verification
South Dakota Board of Pharmacy Wholesale Distributors; Active, in good standing as of October 5, 2018 This document may be used as a Primary Source Verification Full License Firm Name DBA Address 1 Address 2 City State ZIP Code Expiration Issued 600-2353 3M COMPANY dba 3M ESPE DENTAL PRODUCTS 2111 MCGAW AVE IRVINE CA 92614 12/31/2018 11/10/2014 3M COMPANY-CRITICAL & CHRONIC 600-1277 CARE SOLUTIONS DIVISION dba 3M 601 22ND AVE S BROOKINGS SD 57006 12/31/2018 03/19/2007 600-0107 A & B WELDING SUPPLY CO INC 914 E CHICAGO ST RAPID CITY SD 57701 12/31/2018 01/28/1992 600-1251 A.F. HAUSER INC 4401 E US HWY 30 VALPARAISO IN 46383 12/31/2018 01/03/2007 600-2272 A.P.I. SOLUTIONS INC 25309 FRIENDSHIP RD DAPHNE AL 36526 12/31/2018 03/06/2014 ABBVIE PATIENT ASSISTANCE 600-1372 FOUNDATION 1 N WAUKEGAN RD D-ZZ22, BLDG AP34 NORTH CHICAGO IL 60064 12/31/2018 11/20/2007 600-2058 ABBVIE US LLC 1 N WAUKEGAN RD D-GS02 BLDG AP5 NORTH CHICAGO IL 60064 12/31/2018 07/19/2012 600-2299 ABRAXIS BIOSCIENCE LLC 86 MORRIS AVE SUMMIT NJ 07901 12/31/2018 05/22/2014 600-2952 ACACIA PHARMA INC 440 STEVENS AVE, SUITE 200 SOLANA BEACH CA 92075 12/31/2019 09/27/2018 600-2358 ACADIA PHARMACEUTICALS INC 3611 VALLEY CENTRE DR STE 300 SAN DIEGO CA 92130 12/31/2018 11/19/2014 600-2409 ACARIAHEALTH SOLUTIONS INC 6610 W SAM HOUSTON PKWY N#330 HOUSTON TX 77041 12/31/2018 04/06/2015 600-1552 ACCERA INC 3005 CENTER GREEN DR #205 BOULDER CO 80301 12/31/2018 01/08/2009 600-2657 ACCORD BIOPHARMA INC 1009 SLATER RD STE 210-B DURHAM NC 27703 12/31/2018 11/07/2016 600-1472 ACCORD HEALTHCARE
[Show full text]
Discovering and Developing Innovative New Medicines Designed to Extend and Enhance the Quality of Human Life
® Discovering and developing innovative new medicines designed to extend and enhance the quality of human life. 2011 Annual Report Company Profile Athersys is an international, clinical-stage biotechnology company that is focused on developing novel and proprietary best-in-class therapies designed to treat significant unmet medical needs that extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived “off-the- shelf” stem cell product platform for multiple disease indications in the inflammatory & immune, neurological and cardiovascular disease areas. Current clinical-stage programs include: an ongoing Phase II trial to treat inflammatory bowel disease (partnered with Pfizer); an ongoing Phase II trial to treat damage from ischemic stroke; a recently completed Phase I trial to treat damage from acute myocardial infarction (heart attack); and a recently completed Phase I trial to prevent or reduce GvHD. MultiStem® Production Process Athersys has forged a network of strategic Scalable & Consistent alliances and collaborations with leading pharmaceutical and biotechnology Isolate Material “Off-the-shelf” Product with from Qualified Commercial Scalability Thaw & Administer companies, as well as world- Adult Donor (No tissue matching– renowned research and clinical Lot Release & Product allogeneic product) Characterization Testing Hundreds of thousands institutions in the United to millions of doses States and Europe to PRODUCT STERILITY obtained per donor further develop its Cell Isolation
[Show full text]
Corporate Ghg Inventorying and Target Setting Self-Assessment: V1.0
APPENDIX Corporate GHG Inventorying and Target Setting Self - Assessment : V1.0 Development and Methodology April 2020 APPENDIX: CORPORATE GHG INVENTORYING AND TARGET SETTING SELF-ASSESSMENT: V1.0 Purpose of this Self-Assessment and How it Can Lead to Action Companies are often in a stronger position to improve their greenhouse gas (GHG) management efforts once they understand their relative performance compared to their peers. In response to stakeholder interest, this self-assessment is designed to help companies estimate, at a high level, how their GHG inventorying and target-setting approaches compare to large peer companies representing different industry sectors. Once companies estimate how their key GHG measurement and target-setting efforts compare to their peers, they can evaluate, in greater detail, how other companies approach GHG inventorying and target setting. Helping companies locate their GHG management efforts within the broader market may spur competition, garner internal support for widening the scope of their GHG inventories or setting more aggressive GHG reduction targets, and prioritize resources to implement GHG reduction activities. • Entry-level: For companies beginning to address their GHG emissions, this resource aims to help them identify which inventorying and target-setting actions reflect common business practices today and provide them with a roadmap for developing their own inventories and setting targets. • Intermediate: For companies further along their sustainability journey, this self- assessment can validate more advanced inventorying and target-setting behaviors that position them to deepen GHG emission reductions. • Advanced: For leading companies, this resource can also validate their efforts and encourage them to explore implementing more cutting edge GHG management efforts, eventually pushing such innovations into the mainstream and sharing practices with others.
[Show full text]
Sheffield Teaching Hospitals NHS Foundation Trust Procurement
Sheffield Teaching Hospitals NHS Foundation Trust 07-JAN-2019 14:46:09 Procurement Transparency Payments December-2018 Supplier Value Paid 365 HEALTHCARE 2,730.00 3B TRAINING LTD 4,332.00 3M UNITED KINGDOM PLC 48.78 3M UNITEK UK (ORTHODONTIC PRODUCTS) 1,913.84 7 HILLS LEISURE TRUST 9,332.37 A & S DENTAL 196.56 A ALGEO LTD 31.36 A BOWNES WEBSTER 169.76 A CRAVEN 19.84 A CUMBERLIDGE LTD 4,780.56 A DAY 234.00 A FORRESTER 2,532.30 A GANNAWAY 30.56 A GRAFTON 1,398.90 A HOGG 100.00 A HOOGKAMER 65.77 A HOWARD 129.20 A J HURDLEY 39.10 A L CLINICIAN LIMITED 4,282.00 A LITTLEWOOD 32.00 A LITTLEWOOD 14.40 A M TIME SERVICES 112.68 A MARSHALL 568.40 A MAZAI 5,701.00 A P MACKIE 310.40 A R M ANDRZEJOWSKI 364.00 A RIDSDALE 7,873.86 A SLATER 260.91 A SOMERVILLE LTD 88.37 A SWAIN 15.60 A TAYLOR 29.00 A W BENT LTD 327.26 A WOOD 355.83 A WRIGHT 1,310.08 A&F SPRINKLERS LTD 302.40 A. GAGE OPTICIANS LTD 39.10 AAH PHARMACEUTICALS LTD 1,113,707.10 ABATRON LTD 346.18 ABBOTT LABORATORIES LTD 4,229.46 ABBOTT MEDICAL UK LTD 141,181.20 ABBOTT VASCULAR 48,466.80 ABBVIE LTD 17,765.18 ABILITY HANDLING LTD 482.98 AC MAINTENANCE LTD 5,206.80 ACCIDENT & EMERGENCY AGENCY LIMITED 792.56 Page 1 of 36 Supplier Value Paid ACCORD FLOORING LTD 5,780.92 ACE JANITORIAL SUPPLIES LIMITED 5,159.34 ACORN INDUSTRIAL SERVICES LTD 331.55 ACROSTAK 2,061.60 ACTION ON HEARING LOSS 99.67 ACTIVE DOCUMENTS LTD 2,094.00 ACUMED LTD 3,833.88 ADAM ROUILLY LTD 985.20 ADARE SEC LIMITED 197.90 ADEC DENTAL UK LTD 1,375.56 ADECCO UK LTD 32,195.88 ADEPT LOCUMS LTD 398.35 ADMIRAL DENTAL LABORATORY LTD 181.00
[Show full text]
CAN Company Name 005004 3 M Company 005010 a a a 007372 a O N Corporation 005207 a T & T Corp 020609 Abbvie Corp. 017610
CAN Company Name 005004 3 M Company 005010 A A A 007372 A O N Corporation 005207 A T & T Corp 020609 Abbvie Corp. 017610 Accenture Ltd. 008785 Adidas Corp 017083 Advanced Micro Devices 020742 Aflac - Corp. Only 015372 Alcon Laboratories 010362 Aldi Inc 018393 Allergan Inc 017645 Allianz Life Insurance Company 005094 Allstate Insurance Company 023232 Amazon-CV PC 005113 American Airlines 020340 American Association of Physicians of Indian Origin 005120 American Express Co 009491 Ametek 005156 Amgen Inc 005162 Analog Devices 016851 Apple Inc. 005177 Apria Healthcare 007313 Aramark Corporation 010662 Arbonne International 005184 Archer Daniels Midland Company 007947 ARI 005202 Astrazeneca 019127 At Properties 008478 Automatic Data Processing (A D P) 021944 Avera Health 020190 B.P. 007748 Bacardi Usa Inc 005253 Bank Of America Corp 020495 Baptist Health South Florida 005269 Bausch & Lomb 020705 Baxter International 007383 Becton Dickinson And Company 020749 BI Worldwide 019084 Biogen Idec 020832 Bloomin Brands 005317 Blue Cross Blue Shield 005336 Boston Scientific Corporation 013526 Braintree Laboratories 005349 Bristol-Myers Squibb 018867 Broadcom 005357 Brown-Forman 007403 C B S Broadcasting Inc 005383 C V S 005384 Cablevision 010995 Caesars Entertainment Group 019659 Carefusion Corporation 020683 CARFAX 005407 Carolinas Healthcare System 005415 Caterpillar Inc 018396 Cb Richard Ellis Group 021467 CDK Global Inc. 005450 Chevron USA Inc. 007575 Church Of Jesus Christ L D S 005477 Cisco Systems 005481 Citigroup 006352 Citizens Financial Group
[Show full text]
Post Conference Report
Europe's leading industry update for all clinical development outsourcing professionals 10th Annual Congress and Exhibition 20 11 Leadership for successful clinical partnerships 15-18 November 2011, Cité Centre de Congrès, Lyon, France POST CONFERENCE REPORT • Record attendance for 2011, over 900+ clinical professionals registered to attend • Most comprehensive agenda , over 95+ hours researched interviews conducted • 150 speakers and 70+ practical case studies presented the latest clinical development in the industry • Largest ever group of Vice Presidents, Directors and Heads of Clinical with multi-million Euro purchasing power • Over 350 different companies attended across 31 countries • Partnerships in Clinical Trials Congress and Exhibition continues to be the market leading event for decision makers to attend • 87% of delegates were from Europe • Overall conference experience has been rated 4 out 5 amongst our attendees Participation Statistics Country Representation 20 11 Function Representation 20 11 Western Europe 48% General Managers 25% Vice President 5% Northern Europe 32% Business Development 19% CEO 4% USA 8% Clinical Operations 17% Account Directors 3% Eastern Europe 6% Outsourcing 12% Data Management 2% Southern Europe 4% Logistics Managers 11% Medical Directors 2% Rest of the World 2% Other 6% Alliance 1% Contract Research 5% www.ct-partnerships.com To register: Call: +44 (0) 20 7017 7481 Fax: +44 (0) 20 7017 7823 Email: [email protected] Reasons why PCT remains THE leading clinical conference to attend in
[Show full text]
A Special Thank You to Our Bionj BIO 2015 Host Committee Members!
A Special Thank You to Our BioNJ BIO 2015 Host Committee Members! Nicole Adams, Chromocell Corporation Geert Cauwenbergh, PhD, Dr. Med. Sc., RXi Pharma Sam Alexander, Pavese-McCormick Agency, Inc. Jean Chang, New Jersey Business Action Center Emil Andrusko, Benchworks Paul Chew, MD, Sanofi Domenick Argento, Merck Sharp & Dohme Corp. John Clarke, Cardinal Partners Chris Asakiewicz, PhD, Stevens Institute of Technology Steven Cohen, Morgan, Lewis & Bockius LLP Didi Asistin, Ontario Ministry of Economic Development, Mary Coleman, Agile Therapeutics Trade and Employment Linda Coles Kauffman, New Jersey Business Action Center Solomon Babani, Covance Karen Coviello, WithumSmith+Brown, PC Kim Baez, Helsinn Therapeutics (US), Inc. Kathleen Coviello, New Jersey Economic Development Richard Bagger, Celgene Corporation Authority Jane Baj, PTC Therapeutics, Inc. Irene Crespo, New Jersey Business Action Center Clara Barreneche, Catalonia Trade & Investment ACC10 NY Tony delCampo, Hackensack University Medical Center Gil Bashe, Makovsky + Company, Inc. Pamela Demain, MBA, CLP, Merck & Co., Inc. Brian Batchelder, Imclone Systems/Eli Lilly and Company Bill DeStefano, USI Insurance Services, LLC Patti Becton, Accenture Charles-Henry Dion, UBIFRANCE North America – Boston Office Thad Bench, Benchworks Debra Duffy, PhR, Elusys Therapeutics, Inc. Gina Bencivengo, NJEDA Regina Dutkowski, d3 Medicine Donna Bernard, BDO USA, LLP Jeff Elton, Accenture Kenneth Blank, PhD, Rowan University Bob Esposito, CPA, M.Ace, EisnerAmper, LLP Keith Bostian, PhD, Kean University Eddie Evans, NPS Pharmaceuticals Taryn Bostjanic, CPA, WithumSmith+Brown, PC Karla Ewalt, Princeton University Cheryl Braunstein, Helsinn Therapeutics (US), Inc. Bonnie Featherstone, BonaFide Staffing, LLC Michele Brown, Choose New Jersey Fred Feiner, Yankee Public Relations Linda Burns, Helsinn Therapeutics (US), Inc. Allison Finnegan, American Express Meetings & Events Michele Cahoone , VWR International, LLC Kit Ford, Taiho Oncology, Inc.
[Show full text]
ATRCOUN April 27, 20
January 2016 ▪ Volume 20 ▪ Issue 1 THE FORCE AWAKENS: A were signs of choppiness. The Dow plunged RESURGENCE OF M&A IN in September and the IPO markets have been LAWYER slow to gather steam, with very few successful 2015 IPOs in the fourth quarter. We hate to say it, but the current exuberant pace of M&A deals By Frank Aquila and Melissa Sawyer may not be sustainable unless the capital Frank Aquila and Melissa Sawyer are markets can continue to deliver new, up and partners in the Mergers & Acquisitions Group of Sullivan & Cromwell LLP. The coming companies into the mix of potential views and opinions expressed in this article buyers and targets. Meanwhile, the Fed’s de- are those of the authors and do not necessar- cision to raise interest rates will also surely ily represent those of Sullivan & Cromwell LLP or its clients. have an impact on the M&A environment as Contact: [email protected] or well. [email protected]. After close to a decade of anemic M&A, Best of Enemies: Activism 2015 was “the big year” that dealmakers have Developments been expecting for the last several years. Sig- Activism was somewhat old news in 2015 nicant deals took place across a wide range because activism has largely matured into be- The M&A of sectors and geographies. Dealmaking in ing the “new normal.” The level of engage- health care and life sciences continued to be ment between issuers, activists and institu- very active, but we also saw a lot of deals in tional investors has risen to dizzying heights, consumer and retail (Kraft/Heinz, AB InBev/ with all the attendant professionalization of SABMiller), media (Cablevision/Altice, Charter/Time Warner) and chemicals (Dow/ DuPont, Cytec/Solvay), to name a few IN THIS ISSUE: industries.
[Show full text]
DELAWARE COUNTY LEGAL JOURNAL Vol. 107 No. 37 9/11/20
DELAWARE COUNTY LEGAL JOURNAL Vol. 107 No. 37 9/11/20 ESTATE AND TRUST NOTICES BETTY ANN McCANDLESS, dec’d. Late of the Township of Upper Notice is hereby given that, in the es Providence, Delaware County, PA. tates of the decedents set forth below, the Extr.: Sandy Stefanowicz c/o D. Selaine Register of Wills has granted letters testa Keaton, Esquire, 21 W. Front Street, mentary or of administration to the persons P.O. Box 1970, Media, PA 19063. named. Notice is also hereby given of the D. SELAINE KEATON, ATTY. 21 W. Front Street existence of the trusts of the deceased set P.O. Box 1970 t lors set forth below for whom no personal Media, PA 19063 representatives have been appointed within MARGARET McGONIGLE a/k/a 90 days of death. All persons having claims MARGARET ANN McGONIGLE, or demands against said estates or trusts dec’d. are requested to make known the same, and Late of the Borough of Collingdale, all persons indebted to said estates or trusts Delaware County, PA. are requested to make payment, without Extx.: Catherine M. Gould, 424 Foster delay, to the executors or administrators or Drive, Springfield, PA 19064. trustees or to their attorneys named below. THOMAS H. BROADT, ATTY. Tim Broadt & Associates, PC FIRST PUBLICATION 116 W. Baltimore Avenue JOSEPH EMMETT COADY a/k/a Media, PA 19063 JOSEPH E. COADY, dec’d. ROBERT VOGT MERRELL a/k/a Late of the Borough of Media, ROBERT V. MERRELL, dec’d. Delaware County, PA. Late of the Township of Newtown, Extx.: Corrine A.
[Show full text]
LABORATORY BUSINESS WORLD ISSUE 34 July 2013 a QUARTERLY REVIEW of the GLOBAL SCIENTIFIC PRODUCTS MARKETPLACE
LABORATORY BUSINESS WORLD ISSUE 34 July 2013 A QUARTERLY REVIEW OF THE GLOBAL SCIENTIFIC PRODUCTS MARKETPLACE First quarter disappoints CONTENTS 1 Headline Industry Review as US lab exports plunge 2-3 Industry News The first quarter was a dismal one for the spending from the pharmaceutical and 4-5 End-User Markets laboratory sector, with US manufacturers educational sectors. seeing exports decline on an annual basis Mettler-Toledo found its sales beginning to Lab markets suffer from sluggish for the first time in more than three years, slide in the first quarter, as the firm continued economy and spending cuts in Q1 in the face of on-going cutbacks in US to battle against weakness in the European research funding and a worse-than-expected and Asian markets for its products, while lab 6 International Market Review performance for many key markets. glass giant Corning continued to grow sales Figures from the US International Trade after completing its recent acquisition of BD’s 7-8 Financial Results Table Commission (USITC) for the first quarter of Discovery Labware business. For instrument 2013 showed that exports from producers of market leader Thermo Fisher Scientific, 9 Company Reports laboratory equipment and instrumentation although top-line growth was rather flat, based in the US were 2% lower than a year particularly for analytical instruments, Affymetrix - Danaher ago, slipping to $3.89 billion, with falling the recent closure of its purchase of Life demand from all three of the country’s leading Technologies meant that the firm ended 10 Company Reports trade partners for scientific equipment.
[Show full text]
VOLUME II Public School Code of 1949 Goods and Services
Public School Code of 1949 Goods and Services Expenditures Fiscal Year 2015-2016 VOLUME II Temple University Financial Disclosure Report Purchase of Goods and Services Contracts Notes and Definitions The following report provides the required disclosures for reporting the purchase of goods and services contracts. The University’s Banner Finance System does not include data enabling the distinction between the purchases of goods and services. Therefore, a single report is provided that includes both. Expenditures are categorized in the attached report using the following categories: General Supplies & Services: o General supplies, expendable equipment and software. Health Service Programs: o Animal lab, professional billing and other outside professional services. Insurance: o Malpractice, property, general liability, and employees insurances. Interest & Taxes: o Bond interest, real estate tax and debt service costs. Library: o Books, electronic periodicals, subscriptions and film. Professional Fees & Contracts: o Auditing, legal and collection fees and subcontracts. Property, Plant & Equipment: o Capital equipment, buildings and building improvements. Rent: o Equipment, building and office rentals. Repairs & Maintenance: o Equipment repair, maintenance of buildings and grounds. Telecommunications: o Telephone equipment, data communications and cellular services. Travel: o Travel agency fees, foreign and domestic travel expenses. Utilities: o Electric, gas, water, sewer, steam, chilled water and other miscellaneous utilities expenses. Each entry provides the category into which the purchase falls, the vendor name and address and the amount of the purchase. There is no more than one entry per vendor for a single category within a responsibility center. Purchases of goods and services in the Disclosure Report include those which equal or exceed $1,000 for each vendor from all Budgeted Operating Funds including Temple University Physicians.
[Show full text]